肿瘤与正常组织中18F-FDG PET摄取在PET/MRI与PET/CT上的一致性
该研究前瞻性招募100例癌症患者,同日行18F-FDG PET/CT与PET/MRI,比较肿瘤及生理区域SUV。结果显示肿瘤病灶SUV在两种设备间相关性极佳,生理活性区域相关性稍弱但仍在均值2个标准差内,系统性偏倚及置信区间优于既往文献。
要点
- 肿瘤病灶SUV在PET/MRI与PET/CT间各身体区域及肿瘤类型均呈极佳相关性。
- 生理活性区域(胸主动脉、肝右叶)SUV相关性稍弱,但一致性仍在均值2个标准差内。
- 本研究系统性偏倚及置信区间较既往文献更小或相当。
核心结论
- 18F-FDG PET/MRI在肿瘤学定量评估中作为PET/CT的辅助或替代手段似乎有前景,不依赖于身体区域和肿瘤类型,覆盖广泛SUV范围。
研究设计与样本
- 前瞻性研究,从非选择性、异质性癌症患者组中招募100例受试者,同日行18F-FDG PET/CT与PET/MRI。
- 比较PET/MRI与PET/CT获得的生理区域及肿瘤组织SUV,并与已发表数据基准比较。
- 生理活性测量部位为胸主动脉和肝右叶;肿瘤SUV按癌症类型、身体区域及所有病灶合并组分析。
主要发现
- 肿瘤病灶SUV在PET/MRI与PET/CT间所有身体区域及所有研究肿瘤类型均呈极佳相关性。
- 生理活性区域SUV相关性较不稳健,但一致性水平仍在均值2个标准差内。
- 本研究数据显示系统性偏倚更小或相当、置信限更窄,优于现有比较PET/MRI与PET/CT SUV的文献。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: The aim of this study was to assess the concordance of PET measurements of F-FDG uptake in tumor and normal tissues obtained on Australia's first clinical PET/MRI scanner in comparison to PET/CT, with comparison against published data. METHODS: One hundred subjects were prospectively recruited from an unselected, heterogeneous group of cancer patients to undergo F-FDG PET/CT and PET/MRI on the same day. SUVs of physiological regions and tumor tissues obtained by PET/MRI and PET/CT were compared and benchmarked against existing published data. Physiological activity was measured in the thoracic aorta and right lobe of the liver. Tumor SUVs were analyzed by cancer type, body region, and a combined group of all lesions. RESULTS: There was an excellent correlation between SUV measurements in tumor lesions obtained by PET/MRI and PET/CT, across all body regions and in all tumor types studied. There was a less robust correlation for SUVs measured in areas of physiological activity, but the level of agreement still fell within 2 SDs of mean. Data from this study showed comparable or smaller systemic biases and narrower confidence limits than existing studies in the literature comparing SUVs from PET/MRI and PET/CT. CONCLUSIONS: F-FDG PET/MRI appears promising as an adjunct or alternative to PET/CT for quantitative evaluation in oncology, independent of body region and tumor type, across a wide range of SUVs.
引用
- Law WP, Maggacis N, Jeavons SJ, et al. Concordance of 18F-FDG PET Uptake in Tumor and Normal Tissues on PET/MRI and PET/CT. Clin Nucl Med. 2017. PMID: 28033217. doi:10.1097/RLU.0000000000001514
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。